Linsitinib, an IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye disease
Article in Frontiers in Endocrinology (June 2023)
The most recent citing publication is shown below. View this citation on Dimensions.
Article in Frontiers in Endocrinology (June 2023)